Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Operating Income: 2022-2025

Historic Operating Income for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$49.1 million.

  • Gossamer Bio's Operating Income fell 44.80% to -$49.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$160.8 million, marking a year-over-year decrease of 120.85%. This contributed to the annual value of -$59.9 million for FY2024, which is 67.39% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Operating Income is -$49.1 million, which was down 26.70% from -$38.8 million recorded in Q2 2025.
  • Gossamer Bio's Operating Income's 5-year high stood at $52.1 million during Q2 2024, with a 5-year trough of -$56.0 million in Q3 2022.
  • Over the past 3 years, Gossamer Bio's median Operating Income value was -$40.5 million (recorded in 2023), while the average stood at -$33.5 million.
  • In the last 5 years, Gossamer Bio's Operating Income soared by 212.50% in 2024 and then crashed by 174.42% in 2025.
  • Quarterly analysis of 4 years shows Gossamer Bio's Operating Income stood at -$54.4 million in 2022, then increased by 9.81% to -$49.0 million in 2023, then climbed by 26.31% to -$36.1 million in 2024, then tumbled by 44.80% to -$49.1 million in 2025.
  • Its last three reported values are -$49.1 million in Q3 2025, -$38.8 million for Q2 2025, and -$36.8 million during Q1 2025.